FDA.reportPublic FDA data

Cellisys EX EGF Wrinkle 29 Activator

Manufacturer
DN Company Co., Ltd. | Cosmax, Inc.
Effective date
2019-03-21
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 00:29:05

Label at a glance#

ProductCellisys EX EGF Wrinkle 29 Activator
Active ingredientDIMETHICONE
Label structure8 sections

Indications and uses

INDICATION AND USAGE: Apply to the entire face, especially wrinkle area with patting thoroughly to let sh-Oligopeptide-1 and various nourishments absorb into the skin.

Dosage and administration

DOSAGE AND ADMINISTRATION: Apply proper amount to the skin.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT: Dimethicone 0.5%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS: Water, Glycerin, Butylene Glycol, Hydrogenated Poly(C6-14 Olefin), Cyclopentasiloxane,Cetearyl Alcohol, Macadamia Integrifolia Seed Oil, Octyldodecyl Myristate, Cyclohexasiloxane, Caprylic/Capric Triglyceride, Alcohol Denat., Glyceryl Stearate SE, Arachidyl Alcohol, Hydrogenated Phosphatidylcholine, Propylene Glycol, Behenyl Alcohol, Dipalmitoyl Hydroxyproline, PEG-4 Olivate, Tocopheryl Acetate, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Arachidyl Glucoside, Glyceryl Stearate, PEG-100 Stearate, Isohexadecane, Methylparaben, Phenoxyethanol, BHT, Argania Spinosa Kernel Oil, Caffeine, Ceramide NP, Propylparaben, Hydrogenated Lecithin, Polysorbate 80, Fragrance(Parfum), Stearyl Glycyrrhetinate, Sodium Hyaluronate, Carbomer, Tetrasodium EDTA, Potassium Cetyl Phosphate, Polysorbate 20, Disodium EDTA, Palmitoyl Pentapeptide-4, Sodium Ascorbyl Phosphate. Rosa Multiflora Fruit Extract, sh-Oligopeptide-1

PURPOSE

OTC - PURPOSE SECTION

PURPOSE: Skin protectant, Anti wrinkle

WARNINGS

WARNINGS SECTION

WARNING: For external use only. Avoid contact with eyes. Discontinue use if signs of irritation or rash appear. Keep out of reach of babies and children.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of babies and children.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

INDICATION AND USAGE: Apply to the entire face, especially wrinkle area with patting thoroughly to let sh-Oligopeptide-1 and various nourishments absorb into the skin.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: Apply proper amount to the skin.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60565-01260565-012-01, 60565-012-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
GLYCERINPDC6A3C0OXIACT
DIMETHICONE92RU3N3Y1OACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
275ccb3a-3526-48c3-8386-a3a83da92a713199112f-e8d6-1dc7-e054-00144ff88e882022-11-09WarningsExact identifier
spl set id: 3199112f-e8d6-1dc7-e054-00144ff88e88

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.